Valuation: Xiangxue Pharmaceutical Co.,Ltd.

Capitalization 6.46B 886M 854M 802M 712M 1.27B 77.63B 1.41B 9.67B 3.58B 31.81B 3.32B 3.26B 135B P/E ratio 2022
-7.49x
P/E ratio 2023 -8.73x
Enterprise value 8.74B 1.2B 1.16B 1.09B 964M 1.72B 105B 1.91B 13.08B 4.85B 43.05B 4.5B 4.41B 182B EV / Sales 2022
2.86x
EV / Sales 2023 2.47x
Free-Float
71.53%
Yield 2022 *
-
Yield 2023 -
More valuation ratios * Estimated data
Dynamic Chart
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024 24-10-25 CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 24-08-28 CI
Beijing Liuguitang Enterprise Management Technology Co., Ltd. agreed to acquire 51% stake in Beijing Xiangxue Pharmaceutical Biotechnology Co., Ltd. from Xiangxue Pharmaceutical Co.,Ltd. for CNY 23.9 million. 24-07-18 CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 24-04-29 CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 24-04-24 CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 23-10-27 CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 23-08-28 CI
Ji Qingsong agreed to acquire 18.87% stake in Hubei Tianji Pharmaceutical Co., Ltd. from Xiangxue Pharmaceutical Co.,Ltd. for CNY 200 million. 23-08-01 CI
Xiangxue Pharmaceutical Co.,Ltd. announced that it expects to receive CNY 959.884 million in funding 23-08-01 CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 23-04-27 CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 23-04-21 CI
Xiangxue Pharma Trims Losses in 2022 23-01-24 MT
China's COVID scare sparks run on flu medicines, test kits as far away as Australia 22-12-15 RE
More news
1 day+3.01%
1 week+7.32%
Current month+7.32%
1 month-9.20%
3 months-22.62%
6 months+43.90%
Current year+5.02%
More quotes
1 week
9.66
Extreme 9.66
10.37
1 month
9.34
Extreme 9.34
11.40
Current year
9.34
Extreme 9.34
11.50
1 year
3.00
Extreme 3
16.49
3 years
3.00
Extreme 3
16.49
5 years
3.00
Extreme 3
16.49
10 years
3.00
Extreme 3
51.41
More quotes
Director TitleAgeSince
Chief Executive Officer 63 2010-07-22
Director of Finance/CFO 47 2022-06-29
Chief Tech/Sci/R&D Officer 48 2022-06-29
Manager TitleAgeSince
Chairman 63 2010-07-22
Director/Board Member 58 2012-03-27
Chairman 54 2019-06-27
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
+3.01%+7.32%+214.72%+51.10% 931M
-0.89%-1.47%+2.06%+57.85% 5.27B
+0.28%+4.56%-29.34%-31.65% 3.26B
+0.13%+0.88%-0.20%+9.65% 3.05B
+0.41%+4.98%+18.67%+24.87% 2.93B
+1.50%+1.85%-8.43%-24.89% 2.18B
-1.38%-0.97%+17.47%+67.71% 1.66B
+0.05%+1.47%+16.00%-15.32% 1.56B
+1.40%+4.02%+0.28%-41.33% 1.49B
-0.68%-0.14%+54.03%+48.89% 1.39B
Average +0.38%+2.17%+28.53%+14.69% 2.37B
Weighted average by Cap. +0.12%+1.79%+11.80%+16.53%
See all sector performances

Financials

2022 2023
Net sales 2.19B 300M 289M 272M 241M 429M 26.28B 477M 3.27B 1.21B 10.77B 1.12B 1.1B 45.57B 2.3B 315M 304M 285M 254M 451M 27.63B 502M 3.44B 1.27B 11.32B 1.18B 1.16B 47.91B
Net income -533M -73.15M -70.5M -66.19M -58.79M -105M -6.41B -116M -798M -295M -2.62B -274M -269M -11.11B -389M -53.37M -51.44M -48.29M -42.89M -76.35M -4.67B -84.92M -582M -216M -1.91B -200M -196M -8.1B
Net Debt 2.29B 314M 303M 284M 253M 450M 27.53B 500M 3.43B 1.27B 11.28B 1.18B 1.15B 47.74B 2.28B 313M 302M 284M 252M 448M 27.44B 499M 3.42B 1.27B 11.24B 1.17B 1.15B 47.58B
More financial data * Estimated data
Logo Xiangxue Pharmaceutical Co.,Ltd.
XIANGXUE PHARMACEUTICAL CO.,LTD. is a China-based company principally engaged in the research, development, production and distribution of traditional Chinese medicines and herbal decoction pieces. The Company's main products include antiviral oral liquids, indigowoad root granules, Exocarpium Citri Reticulatae series Chinese patent drugs and herbal decoction pieces, among others. The Company is also involved in the manufacture and sale of medical devices, health products, soft drinks and biological products. The Company distributes its products in domestic market.
Employees
2,644
More about the company
Date Price Change Volume
25-02-06 10.26 ¥ +3.01% 40,326,700

End-of-day quote Shenzhen S.E., February 05, 2025

More quotes
  1. Stock Market
  2. Equities
  3. 300147 Stock